Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has announced that Eisai Laboratorios, a subsidiary of Eisai, has filed for marketing authorization of Belviq as a treatment for chronic weight management with the Brazilian Health Surveillance Agency (Anvisa). Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened at $6.80 in last session, and closed at $6.83, while the day range of ARNA stock is $6.60 – $6.88. The stock showed a positive weekly performance of 14.02%.
Ariad Pharmaceuticals Inc (NASDAQ:ARIA) has received a consensus rating of “Hold” from the twenty-five analysts that are currently covering the company. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $8.14, in last session and closed at $8.33, by gaining 2.08%. The 52 week range of ARIA is $2.15 – $23.00. Company’s market capitalization is $1.55billion.
Weight loss drug maker Vivus Inc. (NASDAQ:VVUS)’s board decided to pay a $104,000 bonus to CEO Seth Fischer, who’s been on the job just five months. VIVUS, Inc. (NASDAQ:VVUS) stock advanced 0.87% and finished the last session at $6.94. The EPS of the stock remained -2.12. Company’s market capitalization is $705.83million.
Investors in MannKind Corp (NASDAQ:MNKD) saw new options become available, for the June 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 135 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. MannKind Corporation (NASDAQ:MNKD) stock opened the session at $5.70, and closed the session at $5.63. The 52 week range of the MNKD stock remained $2.43 – $8.70 and the day range was $5.58 – $5.87.
Leave a Reply